Report from Jean Shaw of Partnerships in Health Information, attending the 14th biennial AHILA congress. This year, for the first time, there is to be a CABI prize for a short report on health information activities in an AHILA member country (known as a chapter). The prize is £500 and is awarded by AHILA/Phi. There will be daily conference reports/blogs.
AHILA14, Day 1.
Professor Maria Musoke's keynote presentation encompassed the main themes of the Congress and AHILA's role in accommodating the huge changes that have taken place over the 30 years of its existence – both the benefits and the challenges. These themes were taken up by the principal guest speakers – the representative for the Minister, for Health and Social Welfare and His Excellency the Vice-President of the United Republic of Tanzania who emphasised the importance of e-health resources in the education and practice of health care and the effects of health on poverty and the national economy.
The next exciting event was the presentation of the CABI prize by His Excellency to Dr. Alison Kinengyere & Glorias Asiimwe (Uganda) for their report on the activities of the Uganda Chapter of AHILA and their aims. Their main focus is, and continues to be, on training and the promotion of continuing professional education.
Then began a rich feast of presentations which addressed some of the challenges to be faced by the information professions: a web based site to improve collaboration and efficiency of clinical trials for new drugs; social media and "infodemiology" of misinformation – its identification and containment; an African perspective on sensitive health-related data; and MEDBOX an online library suitable for health workers in crisis situations.
As Professor Musoke [The University Librarian, Makerere University] emphasised in her keynote address, AHILA and its Chapters must ensure that its structure is able to meet and support the benefits and challenges of ICT in the provision of relevant, safe and secure health information to all who need it.
This report also appears on the Global Health Knowledge Base .
AHILA e-newsletter October 2014
Image: King College London, project Emerald (emerging mental health systems in low- and middle-income countries)
One of the key sessions I attended at the second day of “The world in denial: Global mental health matters”( March 26-27, 2013, Royal Society of Medicine, London) highlighted the existing legal tools available to achieve international recognition of the Right to Health, AND the problems of getting mental health included in this framework. In particular how including it under disability has implications for access to treatment. This blog summarizes the session and puts information into context with current events, including the 66th World Health Assembly recommendations.
There was much I learnt that day, yet of much I was already aware, as CABI’s Global Health
database has 20,000 records on mental health, 25% of them
focussed on developing countries. One of the eye-openers for me was an
understanding of the various legal tools dealing with international
recognition of the Right to Health
and the problems of getting mental health included in this framework;
how including it under disability has implications for access to
This is what I learnt, put simply, from talks given by Professor Norman Sartorius (President of World Psychiatric Association) and Gunilla Backman (Former health adviser SIDA & Editor, The right to health: theory and practice).
Basic Human rights: these are not defined or not universally accepted
There are 5 categories of documents related to human rights
“Nice” is not a word often used in scientific research and when it appears in the UK media, it’s now associated with NICE, National Institute for Health & Clinical Excellence.
More often than not this government organisation makes headlines with bad news: the press reports quickly when a drug is not approved for general use by the NHS. Occasionally the news concerns a drug approval, after a long campaign by an individual and their family.
So attending the Global Health 2011 at the BMA, London, made a very NICE change. It was an eye-opener to see that an offshoot of NICE, “NICE International”, is making a real positive difference to health systems in many countries.
Funded solely by their client countries and international donors (World Bank, DFID and IADB, to name a few), NICE International has sent its adviser teams into Latin America, China, Georgia and India to improve clinical practice and help them develop relevant guidelines. These countries may even set up their very own NICE organisation.
In 2004, a couple of years after I started work for CABI, I heard a talk
by Paul Chinnock, then part of the Cochrane Collaboration, (conduct systematic reviews of the effects of healthcare) and now editor of Tropika.net. Essentially this talk outlined
the need for evidence-based interventions for developing countries: amongst other suggestions, it called for a new
method to analyse evidence from small scale studies and for every Cochrane review to identify the most effective
intervention for both resource-poor and resource-rich settings.
Why was such an evidence base being provided
to the developed world by Cochrane but not to developing countries? To
understand the reason for this, you need to know how they work.